Tuberculosis vector vaccine (Rec-bio)
结核病载体疫苗（瑞科生物）
Report date: 2025/12/11 10:28:25
Base Information
Drug NameTuberculosis vector vaccine (Rec-bio)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Public Health Clinical CenterId Pharma
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesJiangsu Rec-Biotechnology Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A